Anthera Pharmaceuticals Inc
OTC:ANTH
Income Statement
Earnings Waterfall
Anthera Pharmaceuticals Inc
Income Statement
Anthera Pharmaceuticals Inc
| Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
1
|
0
|
0
|
1
|
0
|
1
|
2
|
3
|
4
|
4
|
3
|
3
|
3
|
4
|
3
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+116%
|
1
+135%
|
3
+151%
|
3
-3%
|
3
-9%
|
2
-26%
|
0
-93%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(12)
|
(15)
|
(19)
|
(24)
|
(36)
|
(48)
|
(63)
|
(78)
|
(93)
|
(95)
|
(89)
|
(76)
|
(56)
|
(43)
|
(33)
|
(27)
|
(28)
|
(29)
|
(29)
|
(30)
|
(28)
|
(29)
|
(31)
|
(36)
|
(38)
|
(42)
|
(48)
|
(52)
|
(57)
|
(56)
|
(50)
|
(42)
|
(36)
|
(37)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(11)
|
(12)
|
(11)
|
(10)
|
(8)
|
(9)
|
|
| Research & Development |
(8)
|
(11)
|
(15)
|
(19)
|
(29)
|
(41)
|
(55)
|
(69)
|
(85)
|
(87)
|
(81)
|
(69)
|
(49)
|
(36)
|
(27)
|
(21)
|
(22)
|
(23)
|
(23)
|
(24)
|
(22)
|
(22)
|
(25)
|
(30)
|
(33)
|
(37)
|
(41)
|
(44)
|
(47)
|
(45)
|
(40)
|
(32)
|
(29)
|
(28)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(12)
N/A
|
(15)
-23%
|
(19)
-32%
|
(24)
-26%
|
(36)
-48%
|
(48)
-34%
|
(63)
-31%
|
(78)
-24%
|
(93)
-20%
|
(95)
-2%
|
(89)
+6%
|
(76)
+14%
|
(56)
+27%
|
(43)
+24%
|
(33)
+23%
|
(27)
+17%
|
(28)
-3%
|
(29)
-2%
|
(29)
+0%
|
(30)
-4%
|
(28)
+5%
|
(29)
0%
|
(31)
-7%
|
(35)
-15%
|
(35)
0%
|
(39)
-12%
|
(45)
-14%
|
(50)
-12%
|
(57)
-14%
|
(56)
+2%
|
(50)
+10%
|
(42)
+17%
|
(36)
+13%
|
(37)
-1%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(4)
|
(4)
|
(4)
|
(4)
|
0
|
1
|
0
|
1
|
12
|
15
|
14
|
14
|
3
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
2
|
1
|
10
|
12
|
10
|
13
|
|
| Pre-Tax Income |
(12)
N/A
|
(20)
-60%
|
(24)
-24%
|
(29)
-20%
|
(40)
-40%
|
(48)
-18%
|
(63)
-32%
|
(79)
-26%
|
(95)
-20%
|
(86)
+9%
|
(77)
+11%
|
(66)
+15%
|
(45)
+31%
|
(43)
+4%
|
(38)
+13%
|
(31)
+19%
|
(31)
-1%
|
(31)
-1%
|
(30)
+3%
|
(31)
-4%
|
(30)
+6%
|
(29)
+1%
|
(31)
-6%
|
(35)
-14%
|
(35)
+0%
|
(39)
-12%
|
(45)
-14%
|
(50)
-12%
|
(56)
-11%
|
(55)
+1%
|
(40)
+27%
|
(30)
+25%
|
(27)
+11%
|
(23)
+13%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(12)
|
(20)
|
(24)
|
(29)
|
(40)
|
(48)
|
(63)
|
(79)
|
(95)
|
(86)
|
(77)
|
(66)
|
(45)
|
(43)
|
(38)
|
(31)
|
(31)
|
(31)
|
(30)
|
(31)
|
(30)
|
(29)
|
(31)
|
(35)
|
(35)
|
(39)
|
(45)
|
(50)
|
(56)
|
(55)
|
(40)
|
(30)
|
(27)
|
(23)
|
|
| Net Income (Common) |
(12)
N/A
|
(20)
-60%
|
(24)
-24%
|
(29)
-20%
|
(40)
-40%
|
(48)
-18%
|
(63)
-32%
|
(79)
-26%
|
(95)
-20%
|
(86)
+9%
|
(77)
+11%
|
(66)
+15%
|
(45)
+31%
|
(43)
+4%
|
(38)
+13%
|
(31)
+19%
|
(31)
-1%
|
(31)
-1%
|
(30)
+3%
|
(31)
-4%
|
(30)
+6%
|
(29)
+1%
|
(31)
-6%
|
(35)
-14%
|
(35)
+0%
|
(39)
-12%
|
(45)
-14%
|
(59)
-31%
|
(66)
-13%
|
(68)
-3%
|
(54)
+21%
|
(35)
+35%
|
(29)
+16%
|
(25)
+15%
|
|
| EPS (Diluted) |
-610
N/A
|
-92.95
+85%
|
-68.91
+26%
|
-80.13
-16%
|
-112.25
-40%
|
-93.88
+16%
|
-114.74
-22%
|
-123.78
-8%
|
-164.37
-33%
|
-134.84
+18%
|
-120.17
+11%
|
-60.16
+50%
|
-50.19
+17%
|
-22.36
+55%
|
-15.91
+29%
|
-12.73
+20%
|
-13.52
-6%
|
-12.38
+8%
|
-11.26
+9%
|
-11.04
+2%
|
-10.88
+1%
|
-8.51
+22%
|
-6.91
+19%
|
-7.19
-4%
|
-7.91
-10%
|
-7.84
+1%
|
-8.71
-11%
|
-11.26
-29%
|
-12.87
-14%
|
-10.12
+21%
|
-5.3
+48%
|
-3.17
+40%
|
-2.86
+10%
|
-1.12
+61%
|
|